These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10151029)

  • 1. What will replace TURP?
    Brawer MK; McConnell JD; Oesterling JE
    Contemp Urol; 1992 Feb; 4(2):30-40. PubMed ID: 10151029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostatic hyperplasia: drug and nondrug therapies.
    Bruskewitz RC
    Geriatrics; 1992 Dec; 47(12):39-42, 45. PubMed ID: 1280242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign prostatic hyperplasia. New concepts in the 1990s.
    Moul JW
    Postgrad Med; 1993 Nov; 94(6):141-6, 151-2. PubMed ID: 7694269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of benign prostatic hyperplasia. Alternatives to standard therapy.
    Silverstein JI; Badlani GH; Smith AD
    Clin Geriatr Med; 1990 Feb; 6(1):69-84. PubMed ID: 1689206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current therapies of benign prostatic hypertrophy. Can the new medical treatments replace endoscopic resection?].
    Pavone-Macaluso M
    Ann Urol (Paris); 1992; 26(3):140-4. PubMed ID: 1381162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.
    McConnell JD; Barry MJ; Bruskewitz RC
    Clin Pract Guidel Quick Ref Guide Clin; 1994 Feb; (8):1-17. PubMed ID: 7507389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Benign prostatic hypertrophy: the therapeutic options].
    Pagano F; Zattoni F; Vianello F
    Recenti Prog Med; 1992 Dec; 83(12):696-700. PubMed ID: 1283644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benign prostatic hyperplasia: prostatectomy and alternatives].
    Sulser T
    Ther Umsch; 1995 Jun; 52(6):383-92. PubMed ID: 7541567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urologic diseases in America project: benign prostatic hyperplasia.
    Wei JT; Calhoun E; Jacobsen SJ
    J Urol; 2005 Apr; 173(4):1256-61. PubMed ID: 15758764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BPH: new guidelines based on symptoms and patient preference. The Agency for Health Care Policy and Research.
    Roberts RG
    Geriatrics; 1994 Jul; 49(7):24-31. PubMed ID: 7517377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for benign prostatic hyperplasia.
    Portis AJ; Mador DR
    Can Fam Physician; 1997 Aug; 43():1395-404. PubMed ID: 9266125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral resection of the prostate: still the gold standard?
    Ramsey EW
    Can J Surg; 1993 Feb; 36(1):9-10. PubMed ID: 7680274
    [No Abstract]   [Full Text] [Related]  

  • 15. Benign prostatic hyperplasia: diagnosis and treatment. Benign Prostatic Hyperplasia Guideline Panel. Agency for Health Care Policy and Research.
    Am Fam Physician; 1994 Apr; 49(5):1157-65. PubMed ID: 7512308
    [No Abstract]   [Full Text] [Related]  

  • 16. Benign prostatic hyperplasia (BPH) therapy: when? how? why? the take-home message.
    Marberger M
    J Urol (Paris); 1995; 101(1):56-7. PubMed ID: 7545734
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenesis and medical management of benign prostatic hyperplasia.
    Appell RA
    Semin Nephrol; 1994 Nov; 14(6):531-43. PubMed ID: 7531869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
    Agha AH; Roy JB; Culkin DJ; Lyon K
    Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options in benign prostatic hypertrophy.
    Stone NN
    Hosp Pract (Off Ed); 1992 Oct; 27(10A):85-8, 91-2. PubMed ID: 1383248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non surgical treatment of benign prostatic hypertrophy].
    Martini E; Vaggi L; Rucci A; Di Clemente L
    J Urol (Paris); 1993; 99(6):278-82. PubMed ID: 7516366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.